Media
Read our latest media releases, news and stories to find out what we’re doing and where.
Read our latest media releases, news and stories to find out what we’re doing and where.
Centrient Pharmaceuticals (“Centrient”), the global leader in sustainable antibiotics, next-generation statins and anti-fungals, announced today to have started production at its new statins manufacturing unit. With the building of its second dedicated unit on the Toansa site in India now completed, the company will double its statins production capacity. This will enable Centrient to meet growing demand for its sustainably manufactured Atorvastatin and Rosuvastatin Active Pharmaceutical Ingredients (APIs).
read moreThe second wave of COVID-19 has had a significant impact in India and many hospitals could not provide life-saving oxygen to patients in need.
read moreAt Centrient Pharmaceuticals, Quality, Reliability, and Sustainability are at the heart of everything we do. It shapes how we do things, from manufacturing and distribution to our partnerships and community engagement.
read more